Initial Filing. For the Initial Filing in any Regulated Market in the Territory, FMI shall be responsible for, […***…] providing to Roche and/or its Affiliates (as directed by Roche) the regulatory file that resulted in the Regulatory Approval by the FDA in the US for F1CDx. Roche will pay […***…]. FMI and Roche will share equally […***…].
Appears in 3 contracts
Sources: Ex Us Commercialization Agreement (Foundation Medicine, Inc.), Ex Us Commercialization Agreement, Ex Us Commercialization Agreement (Foundation Medicine, Inc.)